OTCMKTS:BIOYF BioSyent (BIOYF) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free BIOYF Stock Alerts $6.33 -0.04 (-0.63%) (As of 05/6/2024 ET) Add Compare Share Share Today's Range$6.33▼$6.3350-Day Range$6.20▼$6.5152-Week Range$5.26▼$6.97Volume620 shsAverage Volume2,775 shsMarket CapitalizationN/AP/E Ratio31.10Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendShort InterestStock AnalysisChartDividendShort Interest Get BioSyent alerts: Email Address Ad Stansberry ResearchControversial CEO explains new way to amass wealthThere's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject About BioSyentBioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.Read More BIOYF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOYF Stock News HeadlinesApril 23, 2024 | globenewswire.comBioSyent to Attend Planet MicroCap ShowcaseApril 15, 2024 | globenewswire.comBioSyent Announces Extension of RepaGyn® and Proktis-M® AgreementMay 7, 2024 | DTI (Ad)Is Tesla going out of business?Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. April 10, 2024 | globenewswire.comBioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 1, 2024 | globenewswire.comBioSyent to Present at LD Micro New York Investor ConferenceMarch 27, 2024 | globenewswire.comBioSyent Announces Grant of Restricted Share UnitsMarch 13, 2024 | globenewswire.comBioSyent Releases Financial Results for Fourth Quarter and Full Year 2023March 6, 2024 | globenewswire.comBioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024May 7, 2024 | DTI (Ad)The best inflation-proof investment The markets are CRAZY right now. Which is why thousands of investors are flocking into one little-known company. March 6, 2024 | globenewswire.comBioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024February 21, 2024 | globenewswire.comBioSyent Named to 2024 TSX Venture 50August 25, 2021 | financialpost.comBioSyent Releases Q2 and H1 2021 Financial ResultsSee More Headlines Receive BIOYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/15 Dividend2/28/2024Dividend Payable3/15/2024Today5/07/2024Next Earnings (Estimated)5/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BIOYF CUSIPN/A CIKN/A Webwww.biosyent.com Phone(905) 206-0013FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio31.10 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. René C. Goehrum (Age 65)Chairman, CEO & President Comp: $387.86kMr. Robert J. MarchVP of Finance & CFOMr. Joost van der MarkVice President of Corporate DevelopmentMs. Neelu AtwalDirector of Human ResourcesMr. Alfred D'SouzaAdvisorKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors BIOYF Stock Analysis - Frequently Asked Questions How have BIOYF shares performed in 2024? BioSyent's stock was trading at $6.9619 on January 1st, 2024. Since then, BIOYF shares have decreased by 9.1% and is now trading at $6.33. View the best growth stocks for 2024 here. Are investors shorting BioSyent? BioSyent saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 500 shares, a drop of 83.3% from the March 31st total of 3,000 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is currently 0.1 days. View BioSyent's Short Interest. When is BioSyent's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024. View our BIOYF earnings forecast. How often does BioSyent pay dividends? What is the dividend yield for BioSyent? BioSyent declared a dividend on Thursday, February 22nd. Investors of record on Thursday, February 29th will be given a dividend of $0.0332 per share on Friday, March 15th. This represents a dividend yield of 2.08%. The ex-dividend date is Wednesday, February 28th. This is a boost from the stock's previous dividend of $0.03. Read our dividend analysis for BIOYF. How do I buy shares of BioSyent? Shares of BIOYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOYF) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.